| What it does | Research peptides with independent third-party testing and lot-specific documentation
| SEC insider filings screener for Forms 3, 4 and 5
|
|---|
| Stage | Not given
| Startup
|
|---|
| Founded | Not given
| 2026
|
|---|
| Based in | US
| DE
|
|---|
| Pricing model | Paid
| Free
|
|---|
| Pricing | Retail single vials start from $29.99 (GHK-Cu) to $79.99 (SS-31). Mix and Match bundle discounts: 3-5 items save 8%, 6-9 items save 12%, 10+ items save 15%. Wholesale pricing available in 10-vial kits and bulk quantities with volume discounts. Free U.S. shipping on orders over $150.
| Not given
|
|---|
| Key features | - Independent HPLC and mass spectrometry testing on every production lot
- Minimum 99% purity standard verified
- Lot-specific Certificate of Analysis published online
- Same-day dispatch on weekday orders
- 10-vial research kit format for bulk supply
- Mix and Match bundle discounts up to 15%
- Free U.S. shipping on orders over $150
- Tiered wholesale pricing for laboratories and research institutions
- U.S.-based research support available 6 days per week
| - Search SEC Forms 3, 4 and 5 by ticker, reporting owner, filing date, trade date, transaction code, and insider role
- Predefined screens for large purchases, director purchases, officer purchases and large sales
- CSV export for filing data analysis
- API access to normalized transaction data
- Email notifications and alerts for insider filings
- RSS feeds for latest filings and specialist screens
- Filing footnotes preserved for transaction context
- Links to original SEC EDGAR filings for verification
- Filters for non-derivative transactions and specified transaction codes
|
|---|
| What makes it different | - Every batch independently tested by accredited U.S. laboratories with published lot-specific documentation
- Built specifically for structured research procurement, not retail consumer sales
- Transparent batch documentation and Certificates of Analysis published openly online
| - Structures SEC filing data with transaction codes, reporting-owner roles and ownership context rather than just listing raw filings
- Distinguishes actual purchases and sales from grants, option exercises and tax-related transactions
- Preserves filing-level details and source context for informed interpretation
- Provides estimated P/S prices and cash values as screening aids calculated from parsed data
|
| Community votes | 0 | 1 |
| DR (Domain Rating by Ahrefs) | 16 ▲ +1 (up) since last check | 7 ● no change since last check |
| Trust Flow (Majestic) | 17 | 4 |
| Citation Flow (Majestic) | 32 | 16 |
| Referring domains (Majestic) | 43 | 15 |